Samuel Stahly
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: Kansas City University (2023–2025); Unity Health System (2021–2022); Advanced Dermatology & Cosmetic Surgery (2023–2026); HonorHealth (2021)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Samuel Stahly's research focuses on dermatologic conditions and medical education. He has investigated novel therapeutic indications for existing medications, such as dupilumab for refractory granulomatous tattoo reactions and topical ruxolitinib for granuloma faciale. Stahly has also examined cutaneous changes following SARS-CoV-2 infection and the impact of retinoid exposure on Foxp3 expression in cutaneous T-cell lymphoma. His work includes case reports on rare dermatologic malignancies like Pagetoid Reticulosis. Additionally, Stahly has evaluated educational interventions, specifically surveying the value of "Camp Discovery" in augmenting resident physician education. His publications address a range of skin conditions, from pediatric nail pitting to adult malignancies, and explore the intersection of immunology, pharmacology, and patient care.
Metrics
- h-index: 2
- Publications: 10
- Citations: 11
Selected Publications
-
77283 All-Trans Retinoic Acid Downregulates FOXP3 Expression in Cutaneous T-Cell Lymphoma (2026)
-
Retinoid Exposure Decreases Foxp3 Expression in Cutaneous T‐cell Lymphoma (2020)
Collaboration Network
Top Collaborators
- Retinoid Exposure Decreases Foxp3 Expression in Cutaneous T‐cell Lymphoma
- 77283 All-Trans Retinoic Acid Downregulates FOXP3 Expression in Cutaneous T-Cell Lymphoma
- Retinoid Exposure Decreases Foxp3 Expression in Cutaneous T‐cell Lymphoma
- 77283 All-Trans Retinoic Acid Downregulates FOXP3 Expression in Cutaneous T-Cell Lymphoma
- Retinoid Exposure Decreases Foxp3 Expression in Cutaneous T‐cell Lymphoma
- 77283 All-Trans Retinoic Acid Downregulates FOXP3 Expression in Cutaneous T-Cell Lymphoma
- Retinoid Exposure Decreases Foxp3 Expression in Cutaneous T‐cell Lymphoma
- Retinoid Exposure Decreases Foxp3 Expression in Cutaneous T‐cell Lymphoma
- Retinoid Exposure Decreases Foxp3 Expression in Cutaneous T‐cell Lymphoma
- Retinoid Exposure Decreases Foxp3 Expression in Cutaneous T‐cell Lymphoma
- Retinoid Exposure Decreases Foxp3 Expression in Cutaneous T‐cell Lymphoma
- Retinoid Exposure Decreases Foxp3 Expression in Cutaneous T‐cell Lymphoma
- Retinoid Exposure Decreases Foxp3 Expression in Cutaneous T‐cell Lymphoma
- 77283 All-Trans Retinoic Acid Downregulates FOXP3 Expression in Cutaneous T-Cell Lymphoma
- 77283 All-Trans Retinoic Acid Downregulates FOXP3 Expression in Cutaneous T-Cell Lymphoma
- 77283 All-Trans Retinoic Acid Downregulates FOXP3 Expression in Cutaneous T-Cell Lymphoma
- 77283 All-Trans Retinoic Acid Downregulates FOXP3 Expression in Cutaneous T-Cell Lymphoma
Similar Researchers
Based on overlapping research topics